Cervical Cancer

Researchers Report Breakthrough In HPV Research
UAB (University of Alabama at Birmingham) researchers have developed a new, inexpensive and efficient method for producing and studying a type of human papillomavirus (HPV) that causes cervical cancer. The process could speed understanding of how the virus functions and causes diseases, and lead to new prevention or treatment options.

Kaiser Permanente Data Provides Strong Evidence For Continued Value Of Combined Pap And HPV Testing
Physicians from Kaiser Permanente and the National Cancer Institute report in the March issue of Obstetrics & Gynecology that results from an evaluation of more than 800,000 Pap and HPV tests conducted at Northern California Kaiser Permanente dispel the notion that excessive numbers of women would require increased surveillance and follow-up when HPV testing is implemented. Cervical cancer is a preventable cancer with a primary known cause -- the human papillomavirus (HPV).

Panama HPV Vaccination Program Stirs Debate Over Public Health Education
PRI's "The World" on Friday examined how Panama's campaign to vaccinate all girls against human papillomavirus at age 10 is raising new concerns among some public health experts over how much information the government should disclose about such programs. The vaccine, which requires a three-dose regimen, protects against certain sexually transmitted forms of HPV that cause many cervical cancers, according to "The World.

Screening Cuts Cervical Cancer Rates By Half, UK
In the wake of Jade Goody's tragic story, the latest Cancer Research UK statistics reveal that there is hope on the horizon for cervical cancer. The figures show that women are now half as likely to be diagnosed with cervical cancer as they were when the NHS Cervical Screening Programme began in 1988. The rate of women diagnosed with the disease has halved from 16 per 100,000 in 1988 to 8 per 100,000 according to the latest figures.

Screening Cuts Cervical Cancer Rates By Half, UK
In the wake of Jade Goody's tragic story, the latest Cancer Research UK statistics reveal that there is hope on the horizon for cervical cancer. The figures show that women are now half as likely to be diagnosed with cervical cancer as they were when the NHS Cervical Screening Programme began in 1988. The rate of women diagnosed with the disease has halved from 16 per 100,000 in 1988 to 8 per 100,000 according to the latest figures.

LUMA Cervical Imaging System Installed In Edina At Minnesota Gynecology
SpectraScience, Inc. (OTC Bulletin Board: SCIE), a medical device company, announced that it will place its LUMA(R) Cervical Imaging System to detect pre-cancers at Minnesota Gynecology and Surgery, located in Edina, Minnesota. Dr. James B. Presthus, co-founder of Minnesota Gynecology and Surgery, stated "The introduction of the LUMA System represents our continued dedication in providing the best care possible for our patients.

Helix BioPharma Receives Approval To Initiate Phase II Pharmacokinetic Clinical Study Of Topical Interferon Alpha-2b In Patients With Cervical Lesions
Helix BioPharma Corp. (TSX, FSE: "HBP") announced that it has received the necessary regulatory approvals in Germany to initiate its planned Phase II pharmacokinetic study of Topical Interferon Alpha-2b in patients with low-grade cervical lesions.

Dentists Identify Human Papillomavirus (HPV) Lesion
Human papillomavirus (HPV) is a group of viruses that includes more than 100 different strains or types and is the most common sexually transmitted virus. The American Social Health Association (ASHA) reports that 75 percent or more of sexually active Americans will contract HPV sometime in their lives.

Genetic Differences Help Protect Against Cervical Cancer
Women with certain gene variations appear to be protected against cervical cancer, according to a study led by scientists at Albert Einstein College of Medicine of Yeshiva University and reported in Clinical Cancer Research. Knowing whether or not women have these genetic variants could help physicians to better tailor treatment strategies.

Researchers Report Breakthrough In HPV Research
UAB (University of Alabama at Birmingham) researchers have developed a new, inexpensive and efficient method for producing and studying a type of human papillomavirus (HPV) that causes cervical cancer. The process could speed understanding of how the virus functions and causes diseases, and lead to new prevention or treatment options.

Both Latino And Non-Latino Women Likely To Accept HPV Vaccination For Selves And Children
Most women responding to a survey conducted at Massachusetts General Hospital (MGH) clinics indicated they would be willing to be vaccinated against the human papillomavirus (HPV) and to have their daughters and even sons vaccinated in order to prevent cancer in their children. The report in the March issue of Gynecologic Oncology also found that Latino women are just as likely, if not more so, to accept HPV vaccine as non-Latinos.

Dentists Identify Human Papillomavirus (HPV) Lesion
Human papillomavirus (HPV) is a group of viruses that includes more than 100 different strains or types and is the most common sexually transmitted virus. The American Social Health Association (ASHA) reports that 75 percent or more of sexually active Americans will contract HPV sometime in their lives.

Studies Released At Conference Examine Racial, Ethnic Cancer Disparities
The following summarizes news coverage of studies presented this week at the American Association for Cancer Research's Science of Cancer Health Disparities conference in Carefree, Ariz.

Cervical Cancer - Why Every Woman Should Go For A Smear Test
I Beat Cervical Cancer, But Have Friends Who Refuse To Go For A Smear - I Know How Jade Feels Says Dee 37 "I Beat Cervical Cancer . People Don't Understand How Important It Is To Go For A Smear Test" ... says Dee Standley, 37 from Richmond in London, who was horrified to wake up to the news of Jady Goody's latest prognosis today. She urges every woman to go for their smear tests regularly ...

Guided Therapeutics, Inc. Reports Preliminary Findings From FDA Pivotal Clinical Trial
Guided Therapeutics, Inc. (GT) (Pink Sheets: GTHP) today announced that its LightTouch™ non-invasive cervical cancer detection technology properly identified cervical disease missed by Pap tests and conventional pathology in a multi-site Food and Drug Administration (FDA) pivotal clinical trial. Based on the outcome of the study, GT plans to submit the trial results to the FDA as part of the Premarket Approval (PMA) application for the LightTouch.

Both Latino And Non-Latino Women Likely To Accept HPV Vaccination For Selves And Children
Most women responding to a survey conducted at Massachusetts General Hospital (MGH) clinics indicated they would be willing to be vaccinated against the human papillomavirus (HPV) and to have their daughters and even sons vaccinated in order to prevent cancer in their children. The report in the March issue of Gynecologic Oncology also found that Latino women are just as likely, if not more so, to accept HPV vaccine as non-Latinos.

Cervical Cancer - Why Every Woman Should Go For A Smear Test
I Beat Cervical Cancer, But Have Friends Who Refuse To Go For A Smear - I Know How Jade Feels Says Dee 37 "I Beat Cervical Cancer . People Don't Understand How Important It Is To Go For A Smear Test" ... says Dee Standley, 37 from Richmond in London, who was horrified to wake up to the news of Jady Goody's latest prognosis today. She urges every woman to go for their smear tests regularly ...

Effect Of Male Circumcision On The Prevalence Of High-Risk Human Papillomavirus In Young Men
UroToday.com - Human papillomavirus is the most commonly sexually transmitted infection in the United States. The American Cancer Society estimates that about 11,000 women in the United States will be diagnosed with invasive cervical cancer annually and almost 4,000 will die from this disease. This study done by Dr. Bertran Auvert et al. investigated the association between male circumcision and the prevalence of human papillomavirus among young men.

Louisiana Lawmakers Debate Insurance Mandate For HPV Vaccine Coverage
Legislators in Louisiana on Tuesday debated whether to require that insurance companies cover the cost of vaccinating teen and pre-teen girls against human papillomavirus, a sexually transmitted infection that can cause cervical cancer, the Baton Rouge Advocate reports.

Cervical Cancer: MRI And PET/CT Improve Chances For Optimal Treatment And Minimal Complications
Pretreatment MRI and PET/CT for cervical cancer may direct more women to optimal therapy choices and spare many women potential long-term morbidity and complications of trimodality therapy (surgery followed by chemoradiation), according to a study performed at the Institute for Technology Assessment in Boston, MA.

Screening Cuts Cervical Cancer Rates By Half, UK
In the wake of Jade Goody's tragic story, the latest Cancer Research UK statistics reveal that there is hope on the horizon for cervical cancer. The figures show that women are now half as likely to be diagnosed with cervical cancer as they were when the NHS Cervical Screening Programme began in 1988. The rate of women diagnosed with the disease has halved from 16 per 100,000 in 1988 to 8 per 100,000 according to the latest figures.

Researchers: Guillain-Barre Syndrome After HPV Vaccine Needs Monitoring
The HPV vaccine does not increase the risk of developing Guillain-Barré syndrome, according to a study released that will be presented at the American Academy of Neurology's 61st Annual Meeting in Seattle, April 25 to May 2, 2009. Guillain-Barré is a disorder that causes muscle weakness and tingling that can progress to paralysis. Although it can be life-threatening, most people recover with few remaining problems.

Guided Therapeutics, Inc. Reports Preliminary Findings From FDA Pivotal Clinical Trial
Guided Therapeutics, Inc. (GT) (Pink Sheets: GTHP) today announced that its LightTouch™ non-invasive cervical cancer detection technology properly identified cervical disease missed by Pap tests and conventional pathology in a multi-site Food and Drug Administration (FDA) pivotal clinical trial. Based on the outcome of the study, GT plans to submit the trial results to the FDA as part of the Premarket Approval (PMA) application for the LightTouch.

Wall Street Journal Examines Potential Use Of Gardasil Among Young Men
The Wall Street Journal on Wednesday examined the potential use of Merck's human papillomavirus vaccine Gardasil among young men. The vaccine currently is approved for use in girls and women ages nine to 26 to prevent four types of HPV infections -- two of which can lead to cervical cancer in women and two of which can lead to genital warts in both sexes.

Hispanic, Black Women In California Receive Cervical Cancer Vaccine At Lower Rates, Study Finds
Hispanic and black women in California have lower vaccination rates for the cervical cancer vaccine Gardasil than other women, according to a report released on Tuesday, the Los Angeles Times reports. Gardasil protects against four strains of human papillomavirus, which is associated with about 70% of all cervical cancers in the U.S. and 90% of genital warts.

Hispanic, Black Women In California Receive Cervical Cancer Vaccine At Lower Rates, Study Finds
Hispanic and black women in California have lower vaccination rates for the cervical cancer vaccine Gardasil than other women, according to a report released on Tuesday, the Los Angeles Times reports. Gardasil protects against four strains of human papillomavirus, which is associated with about 70% of all cervical cancers in the U.S. and 90% of genital warts.

GP Journal Focuses On HPV Vaccination, Medicolegal Issues, Management Of Life Threatening Allergies
The January/ February 2009 edition of Australian Family Physician, the flagship journal of The Royal Australian College of General Practitioners (RACGP), features a range of articles and research focusing on key issues in general practice today.

LUMA Cervical Imaging System Installed In Edina At Minnesota Gynecology
SpectraScience, Inc. (OTC Bulletin Board: SCIE), a medical device company, announced that it will place its LUMA(R) Cervical Imaging System to detect pre-cancers at Minnesota Gynecology and Surgery, located in Edina, Minnesota. Dr. James B. Presthus, co-founder of Minnesota Gynecology and Surgery, stated "The introduction of the LUMA System represents our continued dedication in providing the best care possible for our patients.

African Americans Aware And Accepting, But Often Do Not Receive, The HPV Vaccine
Although only 25 percent of eligible African American adolescents have received the HPV vaccine, a new survey presented at the American Association for Cancer Research conference on the Science of Cancer Health Disparities, suggests they have a positive view of the treatment and might respond to more education. The Pennsylvania Department of Public Health is funding research to develop ways to increase the rate of HPV vaccination among those at highest risk.

Wall Street Journal Examines Potential Use Of Gardasil Among Young Men
The Wall Street Journal on Wednesday examined the potential use of Merck's human papillomavirus vaccine Gardasil among young men. The vaccine currently is approved for use in girls and women ages nine to 26 to prevent four types of HPV infections -- two of which can lead to cervical cancer in women and two of which can lead to genital warts in both sexes.